Senores Pharmaceuticals Limited has informed the Exchange about Schedule of Analyst/Investor meeting on May 21, 2025.

Date: May 16, 2025

To, Sr. General Manager Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001

To, Sr. General Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, C-1, Block G Bandra Kurla Complex Bandra (E), Mumbai – 400 051

BSE Scrip Code: 544319

NSE Symbol: SENORES

Dear Sir/Madam,

Sub.: Intimation of Schedule of Analyst / Institutional Investor meetings under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations 2015

Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended from time to time, we would like to inform you that the officials of the Company will be meeting Analysts / Investors (Participants) as per the details below:

Date & Time

Details

21st May 2025 11:00 AM to 04:00 PM (IST)

Centrum Broking Nakshatra Investor Conference

Nature of Meeting

Group / 1x1 Meetings

Place

Mode of Meeting

Mumbai

Physical

Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.

The Investor Presentation is available on the website of the Company viz. www.senorespharma.com.

Kindly note that changes in the above schedule may happen due to exigencies on the part of Participants/ Company.

You are requested to take the same on record.

Thanking you.

For Senores Pharmaceuticals Limited

Vinay Kumar Mishra Company Secretary and Compliance Officer ICSI Membership No.: F11464

Senores Pharmaceuticals Limited  1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park,  Ambali Bopal Road, Ahmedabad‐380054, Gujarat, India

P: +91 79 2999 9857  |  E: info@senorespharma.com  W: www.senorespharma.com  |  CIN No.: L24290GJ2017PLC100263